BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Jabir NR, Firoz CK, Ahmed F, Kamal MA, Hindawi S, Damanhouri GA, Almehdar HA, Tabrez S. Reduction in CD16/CD56 and CD16/CD3/CD56 Natural Killer Cells in Coronary Artery Disease. Immunological Investigations 2017;46:526-35. [DOI: 10.1080/08820139.2017.1306866] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
Number Citing Articles
1 Xu X, Zou R, Liu X, Liu J, Su Q. Epithelial-mesenchymal transition-related genes in coronary artery disease. Open Medicine 2021;17:781-800. [DOI: 10.1515/med-2022-0476] [Reference Citation Analysis]
2 Lebedeva OK, Ermakov AI, Gaikovaya L, Kukharchik GA. Monocytic and lymphocytic inflammatory reaction during myocardial infarction complicated with acute heart failure in patients with type 2 diabetes mellitus. Transl med (Print) 2021;8:6-17. [DOI: 10.18705/2311-4495-2021-8-4-6-17] [Reference Citation Analysis]
3 Rowaiye AB, Asala T, Oli AN, Uzochukwu IC, Akpa A, Esimone CO. The Activating Receptors of Natural Killer Cells and Their Inter-Switching Potentials. Curr Drug Targets 2020;21:1733-51. [PMID: 32914713 DOI: 10.2174/1389450121666200910160929] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
4 Tabrez S, Shait Mohammed MR, Jabir NR, Khan MI. Identification of novel cardiovascular disease associated metabolites using untargeted metabolomics. Biol Chem 2021;402:749-57. [PMID: 33951765 DOI: 10.1515/hsz-2020-0331] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 Kott KA, Vernon ST, Hansen T, de Dreu M, Das SK, Powell J, Fazekas de St Groth B, Di Bartolo BA, McGuire HM, Figtree GA. Single-Cell Immune Profiling in Coronary Artery Disease: The Role of State-of-the-Art Immunophenotyping With Mass Cytometry in the Diagnosis of Atherosclerosis. J Am Heart Assoc 2020;9:e017759. [PMID: 33251927 DOI: 10.1161/JAHA.120.017759] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
6 Recabarren-Leiva D, Burgos CF, Hernández B, Garcïa-García FJ, Castro RI, Guzman L, Fuentes E, Palomo I, Alarcón M. Effects of the age/rage axis in the platelet activation. Int J Biol Macromol 2021;166:1149-61. [PMID: 33161078 DOI: 10.1016/j.ijbiomac.2020.10.270] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
7 Baumer Y, Gutierrez-Huerta CA, Saxena A, Dagur PK, Langerman SD, Tamura K, Ceasar JN, Andrews MR, Mitchell V, Collins BS, Yu Q, Teague HL, Playford MP, Bleck CKE, Mehta NN, McCoy JP, Powell-Wiley TM. Immune cell phenotyping in low blood volumes for assessment of cardiovascular disease risk, development, and progression: a pilot study. J Transl Med 2020;18:29. [PMID: 31952533 DOI: 10.1186/s12967-020-02207-0] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
8 Savchenko AA, Borisov AG, Kudryavcev IV, Belenjuk VD. The phenotype of NK-cells in the dynamics of the post-operative period in patients with peritonitis in depending on the outcome of the disease. Russian Journal of Infection and Immunity 2019;9:539-548. [DOI: 10.15789/2220-7619-2019-3-4-539-548] [Reference Citation Analysis]
9 Khalil H, Abd El Maksoud AI, Alian A, El-Hamady WA, Daif AA, Awad AM, Guirgis AA. Interruption of Autophagosome Formation in Cardiovascular Disease, an Evidence for Protective Response of Autophagy. Immunol Invest 2020;49:249-63. [PMID: 31264496 DOI: 10.1080/08820139.2019.1635619] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 4.7] [Reference Citation Analysis]
10 Ariyanto IA, Estiasari R, Edwar L, Makwana N, Lee S, Price P. Characterization of Natural Killer Cells in HIV Patients Beginning Therapy with a High Burden of Cytomegalovirus. Immunol Invest 2019;48:345-54. [PMID: 30422022 DOI: 10.1080/08820139.2018.1538236] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
11 Paz MFCJ, Gomes AL, Islam MT, Tabrez S, Jabir NR, Alam MZ, Machado KC, de Alencar MVOB, Machado KC, Ali ES, Mishra SK, Gomes LF, Sobral ALP, e Sousa JMC, de Souza GF, Melo‐cavalcante AAC, da Silva J. Assessment of chemotherapy on various biochemical markers in breast cancer patients. J Cell Biochem 2018;119:2923-8. [DOI: 10.1002/jcb.26487] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 3.4] [Reference Citation Analysis]
12 Rai AK, Thakur CP, Kumar P, Saini S, Kureel AK, Kumari S, Seth T, Mitra DK. Decrease in the Frequency of Circulating CD56+CD161+ NK Cells in Human Visceral Leishmaniasis. Immunol Invest 2018;47:125-34. [PMID: 29182405 DOI: 10.1080/08820139.2017.1402925] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
13 . Letter from the Editor 2017. Immunol Invest 2017;46:759-64. [PMID: 29058543 DOI: 10.1080/08820139.2017.1377856] [Reference Citation Analysis]
14 Tabrez S, Ali M, Jabir NR, Firoz CK, Ashraf GM, Hindawi S, Damanhouri GA, Nabil Alama M. A putative association of interleukin-10 promoter polymorphisms with cardiovascular disease: ASSOCIATION OF IL-10 PROMOTER POLYMORPHISMS WITH CVD. IUBMB Life 2017;69:522-7. [DOI: 10.1002/iub.1637] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 3.2] [Reference Citation Analysis]